Warning: Fetal Toxicity
ثبت نشده
چکیده
Its empirical formula is C24H28N2O5•HCl, and its molecular weight is 460.96. Benazeprilat, the active metabolite of benazepril, is a non-sulfhydryl angiotensin-converting enzyme inhibitor. Benazepril is converted to benazeprilat by hepatic cleavage of the ester group. Lotensin is supplied as tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. The inactive ingredients are colloidal silicon dioxide, crospovidone, hydrogenated castor oil (5-mg, 10-mg, and 20-mg tablets), hypromellose, iron oxides, lactose, magnesium stearate (40-mg tablets), microcrystalline cellulose, polysorbate 80, propylene glycol (5-mg and 40-mg tablets), starch, talc, and titanium dioxide.
منابع مشابه
[Questionnaire survey about NSAIDs use in late pregnancy for pharmacists and physicians].
It has been reported the use of nonsteroid anti-inflammatory drugs (NSAIDs) in late pregnancy was associated with potentially fetal toxicity (contraction of fetal ductus areteriosus). According to the package inserts in Japan, many oral NSAIDs are contraindicated to women in late pregnancy, but several oral and topical NSAIDs with case reports of fetal toxicity are not. In the present study, a ...
متن کاملATACAND HCT 16-12.5 (candesartan cilexetil−hydrochlorothiazide) TABLETS, FOR ORAL USE ATACAND HCT 32-12.5 (candesartan cilexetil−hydrochlorothiazide) TABLETS, FOR ORAL USE ATACAND HCT 32–25 (candesartan cilexetil-hydrochlorothiazide) TABLETS, FOR ORAL USE WARNING: FETAL TOXICITY
متن کامل
To Label or Not to Label: the Pros and Cons of Alcohol Warning Labels in Pregnancy
There is a public and professional debate on the usefulness of alcohol warning labels. This paper presents the major arguments in favor and against such labeling in the context of alcohol use in pregnancy. lcohol warning labels were initially introduced in 1989 to provide the public with repetitive reminders of the teratogenic potential of alcohol use. There are strong arguments in favor of the...
متن کاملThese highlights do not include all the information needed to use VALPROATE SODIUM INJECTION, USP safely and effectively. See full prescribing information for VALPROATE SODIUM INJECTION, USP.VALPROATE SODIUM INJECTION, USP for intravenous injectionInitial U.S. Approval: 1996
WARNING: LIFE THREATENING ADVERSE REACTIONS See full prescribing information for complete boxed warning Hepato toxicity, including fatalities, usually during first 6 months o f treatment. Children under the age of two years and patients with mitochondrial disorders are at higher risk. Monitor patients c losely, and perform serum liver testing prior to therapy and at frequent intervals thereafte...
متن کاملZestril (lisinopril) tablets, for oral use lABEL
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZESTRIL safely and effectively. See full prescribing information for ZESTRIL Zestril (lisinopril) tablets, for oral use Initial U.S. Approval: 1988 WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue Zestril as soon as...
متن کاملVALPROIC ACID- valproic acid solution Par Pharmaceutical ----------
WARNINGS: LIFE THREATENING ADVERSE REACTIONS See full prescribing information for complete boxed warning. Hepato toxicity, including fatalities, usually during first 6 months o f treatment. Children under the age of two years and patients with mitochondrial disorders are at higher risk. Monitor patients c losely, and perform serum liver testing prior to therapy and at frequent intervals thereaf...
متن کامل